Established in 2021, the FHMRI Biomarker Collective (FBC) is driven by world-class researchers working together to turn fundamental discoveries into real-world solutions to healthcare challenges.
The Biomarker Collective themes revolve around the development of non-invasive biomarkers to:
These ambitious aims are achievable through our access to in-house, highly curated and expansive human biospecimen libraries (biobanks) and specialised clinical health data registries.
Biomarker discovery
Unbiased screening for putative biomarker detection.
Biomarker analytical validation
Targeted assays optimised for reproducibility and high sensitivity.
Biomarker confirmation
Using complementary methods.
Biomarker clinical validation
Incorporation into clinical development programs and clinical trials.
key technologies, resources and expertise
Across our programs of research, FBC offers access to a range of key resources, expertise, facilities and technologies.
Explore the specialist equipment and expertise available on a user-pay basis across Flinders' Bedford Park and Tonsley campuses and the Flinders Medical Centre.
Our state-of-the-art facilities include:
Expertise of FBC members includes:
Laboratory capabilities include:
RESEARCH PROGRAMS
RESEARCH OUTPUTS
Our members are highly cited, national and international thought leaders in their fields. Recent competitive grants awarded to our members to continue their biomarker research include:
Sturt Rd, Bedford Park
South Australia 5042
South Australia | Northern Territory
Global | Online
CRICOS Provider: 00114A TEQSA Provider ID: PRV12097 TEQSA category: Australian University
Flinders University uses cookies to ensure website functionality, personalisation, and for a variety of purposes described in the website privacy statement. For details about these cookies and how to set your cookie preferences, refer to our website privacy statement.
You consent to the use of our cookies if you proceed.